Cybin Inc. ( CYBN) Q2 2026 Earnings Call November 13, 2025 8:00 AM EST ...
Precigen, Inc. ( PGEN) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good afternoon, ladies and gentlemen, and welcome to the Precigen Third Quarter 2025 Financial Results and Business Update ...
Asahi Kasei Microdevices Corporation (AKM) will showcase its latest sensing technologies for the growing AgeTech and PetTech markets at CES® 2026. The demonstrations, featuring technologies such as ...
Papcemias FDA Approval -- Granted full FDA approval in August with the first and only available treatment for all adults with recurrent respiratory papillomatosis (RRP); label is broad with no ...
Voyager is paying travel partner Transition Bio a single-digit million-dollar upfront payment, with additional payments up to ...
CAMBRIDGE, United Kingdom and LEXINGTON, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Transition Bio, a drug discovery company focused on unlocking ...
Promising results from a new malaria drug offer hope against emerging drug resistance in Africa. In a clinical trial, ...
Tech transfer in oral solid dose (OSD) manufacturing is one of the most critical, and often underestimated, phases in the ...
15hon MSN
Largest RNA language model to date offers new way to predict behavior and boost drug discovery
RNA plays a vital role in how our genes are expressed and how diseases develop. Yet, because RNA molecules constantly change ...
Clinical Outcomes -- Twelve-month study data for the Catamaran implant showed VAS scores decreased from 78.8 to 23, and ODI ...
Transition Bio Inc. and Voyager Therapeutics Inc. have entered into a drug discovery collaboration and license option agreement for novel, selective small molecules for amyotrophic lateral sclerosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback